<?xml version="1.0" encoding="UTF-8"?>
<p id="Par25">This review includes 160 papers (summarised in Fig. 
 <xref rid="Fig1" ref-type="fig">1</xref>, details in Additional file 
 <xref rid="MOESM1" ref-type="media">1</xref>: appendix 4) that describe 39,577 hospitalised patients with A(H1N1)pdm09 and 33,869 treatment courses (Table 
 <xref rid="Tab2" ref-type="table">2</xref>). Twelve different treatments were used, with oseltamivir being the most common (Table 
 <xref rid="Tab2" ref-type="table">2</xref>). The median number of treatments described per manuscript is 63 (interquartile range, IQR 22–193). Of the 160 papers included, two are interventional trials (
 <italic>n</italic> = 73, representing 0.2% of total reported patients), [
 <xref ref-type="bibr" rid="CR6">6</xref>, 
 <xref ref-type="bibr" rid="CR7">7</xref>] 28 are prospective observational studies (
 <italic>n</italic> = 6102, accounting for 15.4% of total patients), 129 are retrospective observational studies or case reports (
 <italic>n</italic> = 33,342, 84.2% of total patients) and one enrolled patients both prospectively and retrospectively (
 <italic>n</italic> = 98, 0.2% of patients). 
</p>
